HEPION PHARMACEUTICALS, INC. Earnings Per Share (Basic)
HEPION PHARMACEUTICALS, INC. (HEPA) reported Earnings Per Share (Basic) of -$0.08 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.08.
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.07.
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.04.
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.09.
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$0.88.
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$107.35.
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$616.07.
- HEPION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$11.90.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.08 10-Q · filed 2026-08-13 | -$0.15 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$0.07 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$0.88 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$0.04 10-Q · filed 2025-11-12 | -$0.88 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$0.09 10-Q · filed 2026-08-13 | -$1.00 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$2.15 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | -$107.35 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | -$36.21 10-Q · filed 2025-11-12 | -$0.72 10-Q · filed 2024-11-14 | -$99.18 10-Q · filed 2025-11-12 | -$1.98 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | -$34.00 10-Q · filed 2025-08-14 | -$0.68 10-Q · filed 2024-08-13 | -$62.50 10-Q · filed 2025-08-14 | -$1.25 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | -$28.13 10-Q · filed 2025-05-19 | -$0.56 10-Q · filed 2024-05-21 | ||||||
| 2023-12-31 | -$616.07 10-K · filed 2025-04-08 | -$12.32 10-K · filed 2024-04-16 | ||||||
| 2023-09-30 | -$2.74 10-Q · filed 2024-11-14 | -$9.90 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | -$3.68 10-Q · filed 2024-08-13 | -$7.16 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | -$3.48 10-Q · filed 2024-05-21 | |||||||
| 2022-12-31 | -$11.90 10-K · filed 2024-04-16 | -$0.59 10-K · filed 2023-04-10 | ||||||
| 2022-09-30 | -$2.24 10-Q · filed 2023-11-20 | -$0.11 10-Q · filed 2022-11-14 | -$9.28 10-Q · filed 2023-11-20 | -$0.46 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$5.22 10-Q · filed 2023-08-14 | -$0.26 10-Q · filed 2022-08-15 | -$7.04 10-Q · filed 2023-08-14 | -$0.35 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | -$1.82 10-Q · filed 2023-05-12 | -$0.09 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-04-10 | -$0.25 derived: net income ÷ weighted average shares · filed 2023-04-10 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-04-10 | -$0.47 10-K · filed 2023-04-10 | ||||
| 2021-09-30 | -$0.12 10-Q · filed 2022-11-14 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.34 10-Q · filed 2022-11-14 | -$0.50 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||||
| 2021-06-30 | -$0.10 10-Q · filed 2022-08-15 | -$0.21 10-Q · filed 2022-08-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-08-15 | -$0.65 derived: net income ÷ weighted average shares · filed 2022-08-15 | ||||
| 2021-03-31 | -$0.12 10-Q · filed 2022-05-16 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$1.03 derived: net income ÷ weighted average shares · filed 2022-05-16 | ||||
| 2020-12-31 | -$0.29 derived: net income ÷ weighted average shares · filed 2022-04-08 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-04-08 | -$1.41 derived: net income ÷ weighted average shares · filed 2022-04-08 | -$2.10 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | -$0.69 10-Q · filed 2021-11-15 | -$1.28 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$2.11 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$0.58 10-Q · filed 2021-08-16 | -$1.43 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$0.97 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | -$5.95 10-K · filed 2020-05-14 | |||||||
| 2019-03-31 | -$0.11 10-Q · filed 2019-05-15 | |||||||
| 2018-12-31 | -$97.35 10-K · filed 2020-05-14 | -$1.39 10-K · filed 2019-03-14 | ||||||
| 2018-03-31 | -$0.27 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | -$0.78 10-K · filed 2019-03-14 | -$0.10 10-KT · filed 2018-03-26 | ||||||
| 2017-06-30 | -$2.04 10-K · filed 2019-03-14 | -$0.26 10-K · filed 2017-09-28 | ||||||
| 2016-12-31 | -$0.19 10-KT · filed 2018-03-26 | |||||||
| 2016-06-30 | -$0.63 10-KT · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |